Abeona Therapeutics (ABEO) Interest Expense - Others (2018 - 2022)
Abeona Therapeutics' (ABEO) quarterly Interest Expense - Others came in at $200000.0 in Q1 2022, down 84.93% quarter-over-quarter from $1.3 million in Q3 2020.
Abeona Therapeutics (ABEO) Interest Expense - Others (2018 - 2022) Analysis & Trends
Abeona Therapeutics' Interest Expense - Others history runs 3 years deep, the most recent figure standing at $200000.0 for Q1 2022.
- On a quarterly basis, Interest Expense - Others changed N/A year-over-year to $200000.0 in Q1 2022; TTM through Mar 2022 was $1.5 million, a N/A change from a year earlier, with the FY2021 full-year figure at $67000.0, down 98.37% from the prior year.
- Interest Expense - Others fell to $200000.0 in Q1 2022 per ABEO's latest filing, from $1.3 million in the prior quarter.
- Across five years, Interest Expense - Others topped out at $1.3 million in Q3 2020 and bottomed at $2000.0 in Q4 2018.
- The 3-year median for Interest Expense - Others is $101500.0 (2018), against an average of $383000.0.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 200,000.00 |
| Sep 30, 2020 | 1.33 Mn |
| Dec 31, 2018 | 2,000.00 |
| Sep 30, 2018 | 3,000.00 |